Vertiv's demand is accelerating, so GLJ Research's $188 target against a $255 stock and a consensus near $350 looks badly wrong. Vertiv's orders doubled and deferred revenue just posted the biggest jump in company history; customers prepaying at records is not how a cyclical downturn starts. GLJ's similar sell call on GE Vernova as a cyclical turbine maker failed: the stock now trades above $1,000, over double its target, and its CEO is selling delivery slots for 2032. x.com
